Chemoinformaics analysis of 9,10,13-TRIHYDROXY-OCTADEC-11-ENOIC-ACID
Molecular Weight | 608.854 | nRot | 30 |
Heavy Atom Molecular Weight | 544.342 | nRig | 1 |
Exact Molecular Weight | 608.45 | nRing | 0 |
Solubility: LogS | -2.613 | nHRing | 0 |
Solubility: LogP | 1.819 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 106 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 64 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 10 | No. of Arom Bond | 0 |
nHA | 8 | APOL | 104.135 |
nHD | 8 | BPOL | 65.9412 |
QED | 0.348 |
Synth | 2.931 |
Natural Product Likeliness | 0.983 |
NR-PPAR-gamma | 0.883 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.097 |
Pgp-sub | 0.003 |
HIA | 0.646 |
CACO-2 | -5.404 |
MDCK | 0.0000599 |
BBB | 0.501 |
PPB | 0.870868 |
VDSS | 0.459 |
FU | 0.0760257 |
CYP1A2-inh | 0.046 |
CYP1A2-sub | 0.131 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.057 |
CYP2c9-inh | 0.008 |
CYP2c9-sub | 0.96 |
CYP2d6-inh | 0.002 |
CYP2d6-sub | 0.073 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.011 |
CL | 6.776 |
T12 | 0.864 |
hERG | 0.037 |
Ames | 0.009 |
ROA | 0.005 |
SkinSen | 0.322 |
Carcinogencity | 0.045 |
EI | 0.376 |
Respiratory | 0.041 |
NR-Aromatase | 0.167 |
Antiviral | Yes |
Prediction | 0.644336 |